Product/Composition:- | Metronidazole Tablets and Capsules |
---|---|
Strength:- | 250 mg, 500 mg |
Form:- | Oral Tablets and Capsules |
Reference Brands:- | Flagyl(US) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Metronidazole inhibits bacterial and protozoal DNA synthesis by disrupting nucleic acid structure. It effectively treats anaerobic infections, including abscesses, pelvic inflammatory disease, and protozoal infections. Benefits include rapid bacterial eradication, good tissue penetration, and oral convenience, making it a reliable option for treating various anaerobic and parasitic infections.
Metronidazole tablets are approved in the EU and US for anaerobic bacterial and protozoal infections. In the EU, brands like Flagyl are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data, with generic options widely available. Both regions require detailed dossiers, including clinical trial results, quality assurance, and pharmacovigilance plans for approval and ongoing safety. For expert regulatory support, dossier preparation, and compliance, visit PharmaTradz. We facilitate seamless market access for metronidazole tablets, ensuring adherence to European and US standards for safe, effective antimicrobial therapy.